The role of chemotherapy in the current treatment of gastric cancer.
about
Chemotherapy beyond second-line in advanced gastric cancerStable transfection of extrinsic Smac gene enhances apoptosis-inducing effects of chemotherapeutic drugs on gastric cancer cells.A retrospective analysis of second-line chemotherapy in patients with advanced gastric cancerAndrographolide induces apoptotic and non-apoptotic death and enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in gastric cancer cells.Molecular targeting to treat gastric cancer.Transcription factor Sp1 expression in gastric cancer and its relationship to long-term prognosis.Phase I trial of capecitabine plus everolimus (RAD001) in patients with previously treated metastatic gastric cancer.Randomised phase II trial of docetaxel and sunitinib in patients with metastatic gastric cancer who were previously treated with fluoropyrimidine and platinum.To Excavate Biomarkers Predictive of the Response for Capecitabine plus RAD001 through Nanostring-Based Multigene Assay in Advanced Gastric Cancer Patients.Calpain regulates thymidylate synthase-5-fluoro-dUMP complex levels associated with response to 5-fluorouracil in gastric cancer cells.Phase II trial of capecitabine and everolimus (RAD001) combination in refractory gastric cancer patients.The prognostic significance of chemotherapy for stage IV gastric cancer patients: a single-institution experience.Outcomes in elderly patients treated with a single-agent or combination regimen as first-line chemotherapy for recurrent or metastatic gastric cancer.How does inhibition of the renin-angiotensin system affect the prognosis of advanced gastric cancer patients receiving platinum-based chemotherapy?.Low-dose capecitabine plus trastuzumab as first-line treatment in patients 75 years of age or older with HER2-positive advanced gastric cancer: a pilot study.Is chemotherapy in elderly patients with metastatic or recurrent gastric cancer as tolerable and effective as in younger patients?
P2860
Q26798288-9233DCDE-E13B-40B4-BDE7-577F6EAE2758Q33210192-CD03B9CE-42A4-4832-AFDA-C1A2133D0C93Q33428751-9B9385B2-E912-48B6-84D0-7B6FACCA5AD9Q33685962-25EEE9BC-56DD-427B-89EA-3F580CF48E78Q34326593-06364F69-5C0C-42DF-B9D9-8E55CA06A5D7Q35010828-5E3778D8-C43A-4EB6-9F9B-3BB640A81F70Q35069652-A82B0DEF-B2EE-44EF-A80C-0456901E18AFQ35927364-5ACB5D89-6058-4A42-B33E-38CE7F15298CQ37514034-8B266874-E9A0-4EFF-A423-E7F170287CC9Q39544715-0C1E0194-7E49-47BC-8554-2432584DB051Q44216566-5DA04C22-309F-4E44-9892-8E51C7AAB948Q44898596-9209BF4E-381D-40F9-A057-1C2B05B12031Q50647977-344A4E67-B9CA-4665-B68A-DF852EB85815Q53140602-9D04897B-0749-4DA2-9106-309AF4481727Q53190180-A9F0A44E-861A-4851-8A9B-6EB43682D0F0Q53379444-3C14C897-C7E0-4BE2-85A9-C58E459B48EA
P2860
The role of chemotherapy in the current treatment of gastric cancer.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The role of chemotherapy in the current treatment of gastric cancer.
@ast
The role of chemotherapy in the current treatment of gastric cancer.
@en
type
label
The role of chemotherapy in the current treatment of gastric cancer.
@ast
The role of chemotherapy in the current treatment of gastric cancer.
@en
prefLabel
The role of chemotherapy in the current treatment of gastric cancer.
@ast
The role of chemotherapy in the current treatment of gastric cancer.
@en
P2860
P1433
P1476
The role of chemotherapy in the current treatment of gastric cancer.
@en
P2093
Atsushi Ohtsu
Daniel Haller
P2860
P2888
P356
10.1007/S10120-002-0219-Y
P478
P577
2002-01-01T00:00:00Z